Global Dengue Vaccines Market to Expand at CAGR of 11% during Forecast Period, Observes TMR Study

ALBANY, N.Y., Jan. 19, 2022 /PRNewswire/ -- The global dengue vaccines market was valued at US$ 0.4 Bn in 2020 and is estimated to rise at CAGR of 11% during the forecast period, from 2021 to 2031. Mosquito reproduction and proliferation are aided by interrupted sanitation services and limited water supplies whilst mosquitos have a longer active season due to warm weather. Climate change is expected to increase the prevalence of dengue fever, which is expected to foster the expansion of the global dengue vaccines market.

Request Brochure of Dengue Vaccines Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28397 

Due to increasing incidence of dengue, presence of rapidly developing healthcare sector, and constant innovation in dengue vaccines, the market in Asia Pacific is predicted to grow at a high CAGR during the forecast period.  In the global dengue vaccines market, the region holds several growth prospects.

As the virus has antigenically four distinct serotypes, developing dengue vaccines is considered difficult. Manufacturers of dengue vaccine are trying to build robust foundation for this research in order to develop vaccines that are effective against all four serotypes at the same time. There are many vaccine candidates under development, with a focus on live attenuated virus vaccines, live chimeric virus vaccines, and subunit vaccinations, among others. As a result, the Butantan/Merck vaccine has received a lot of attention as it contains three full-genomes of the four dengue virus serotypes.

Request for Analysis of COVID-19 Impact on Dengue Vaccines Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=28397

Key Findings of Market Report

• Sequential vaccination, in addition to a heterologous prime-boost method, is becoming more popular in order to increase tetravalent protection. Firms in the global dengue vaccines market are likely to engage with researchers such as those at the Singapore-MIT Alliance for Research and Technology (SMART), who are taking advantage of the opportunity to render sequential vaccination safer and more efficacious than the present tetravalent vaccine.
• Investing in vaccine R&D is quickly becoming one of the most important approaches for gaining a competitive advantage in the global dengue vaccines market. The development of next-generation malaria, dengue, and TB vaccines is likely to be aided by ongoing research. Increasing manufacturing, greater acceptance, and cost effectiveness of dengue vaccines are important determining criteria for their performance in the market environment. Therefore, R&D has become a necessity.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=28397

• Dengue vaccine developers in India and throughout the world are taking advantage of collaboration of regulatory agencies, such as the WHO, with policymakers to standardize field testing for safe and effective dengue vaccinations. The Indo-US Vaccine Action Program is rising in prominence as a means of improving existing vaccine research knowledge.
• Due to rising public knowledge about vaccination, more government funding for vaccination programs, and increase in the occurrence of infectious illnesses, the live attenuated vaccines segment is likely to lead the global dengue vaccines market in the forthcoming years
• Manufacturers in the global dengue vaccines market are putting greater emphasis on the manufacture of vaccines that can avert dengue in people aged 4 years to 60 years. They are enabling market growth in nations such as Singapore, Thailand, and Malaysia, among others. Thus, Asia Pacific is predicted to hold substantial revenue share of the global market during the forecast period.

Buy Dengue Vaccines Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=28397&ltype=S 

Global Dengue Vaccines Market: Growth Drivers

• The global dengue vaccines market was led by the subcutaneous category in 2020. Subcutaneous injection has the benefit of being able to provide vaccines to patients without the need for skilled people, and adsorption, although slow, is generally complete.
• The CYD-TDV (Dengvaxia) segment led the global dengue vaccines market in 2020, as the vaccine was found to be roughly 76% effective in avoiding laboratory-confirmed, symptomatic dengue in people aged 9 years to 16 years who had previously experienced laboratory-confirmed dengue illness

Global Dengue Vaccines Market: Key Players

Some of the key market players are

• Takeda Pharmaceutical Company Limited
• Serum Institute of India Pvt. Ltd
• Panacea Biotec Limited
• Sanofi Pasteur Limited
• GeneOne Life Science
• Sun Pharmaceutical Industries Ltd.

Global Dengue Vaccines Market: Segmentation

Category

• Live Attenuated Vaccines
• Chimeric Live Attenuated Vaccines
• Others

Product

• CYD-TDV (Dengvaxia)
• Others

Route of Administration

• Subcutaneous
• Others

End User

• Hospitals
• Government Institutes
• Specialty Clinics
• Others

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Metagenomics Market: Rapid expansion of the life sciences industry, increase in the number of clinical and diagnostics laboratories, adoption of metagenomics sequencing, rise in application of metagenomics study in genomics & proteomics, and shift in focus on research & development are anticipated to augment the global metagenomics market during the forecast period.

Medical Foods Market: Global medical foods market was valued at US$ 18 Bn in 2018 and is projected to grow at a rapid pace from 2019 to 2027. Medical foods are a special group of FDA-regulated products that meet the distinctive dietary needs or metabolic defects of a medical illness.

Dental Consumables Market: Global dental consumables market was valued at US$ 23,718.0 Mn in 2018 and is projected to expand at a CAGR of 5.4% from 2019 to 2027. Dental consumables primarily comprises of dental implants, crowns and bridges, dental biomaterial, orthodontics, endodontics, and periodontics.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/dengue-vaccine-market.htm 

SOURCE Transparency Market Research